Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

30

Revenue 2017

Botox/Neuromodulator

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Botox/Neuromodulator was produced by Allergan.

Allergan inks $2.1bn deal to buy cosmetic drug firm Kythera

Allergan inks $2.1bn deal to buy cosmetic drug firm Kythera Botox manufacturer Allergan has extended its position in the growing cosmetic or 'aesthetic' pharmaceuticals sector with the purchase, which adds Kythera's double chin therapy Kybella to its portfolio. . ... sales channels already in place for wrinkle

Kythera bags FDA approval for double chin therapy

Kythera bags FDA approval for double chin therapy injected under the chin and is tipped by some market observers as being the next Botox. ... Earlier this month the FDA warned of yet another incident in which counterfeit Botox may have found its way into doctors' offices and medical clinics nationwide.

Actavis completes $70.5bn Allergan acquisition

Actavis completes $70.5bn Allergan acquisition Actavis will also be buying into Allergan's lead product Botox, which has over the past five years gained more medical-based licences outside of its cosmetic indications, and is seen

Valeant lead bidder for troubled Dendreon

Valeant lead bidder for troubled Dendreon Valeant's main interest in 2014 was Botox manufacturer Allergan.

Actavis looks to PepsiCo for CFO

Actavis looks to PepsiCo for CFO She now moves to a role in healthcare at Actavis, which is in the middle of increasing its business with the purchase of Allergan, the makers of Botox and several eyecare

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics